SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsHighNeutral
Announced Fri, 3 Jul · 15:48 IST

FY26 audited results, dividend, office shift to Maharashtra, renewable energy deal

Pat Growth 25pctResults RestatedExceptional ItemResults View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹609.50
prior close
₹610.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.6-0.0-0.4-2.0-1.6+2.5+2.9+3.5+5.8+1.9
Up moveDown movePending
AI summary

Shilpa Medicare FY26 standalone: total income Rs 63,517 lakhs vs 54,708; net profit Rs 13,297 lakhs vs 6,594 (over 2x). EPS Rs 6.80 vs 3.48. Final dividend of Rs 0.60 per share declared. Auditors gave unmodified opinion. Subsidiaries to invest 28 percent in Neo Green Power for captive renewable energy. Board approved shifting registered office from Karnataka to Maharashtra via postal ballot. Prior year figures restated for business combination.

Likely market impact

Strong earnings growth and dividend are positive for shareholders. Office shift and energy investment are operational moves, no material risk signalled.